Friday, May 22, 2020
The first human trial of a COVID-19 vaccine finds that it is safe, well-tolerated, and induces a rapid immune response
Researchers in China conducted a phase 1 trial of an Ad5 vectored COVID-19 vaccine. They used a vaccine that contains a part of the virus and checked if it's safe and if it helps the immune system. They gave different doses to 108 healthy adults. Most people had mild side effects like pain, fever, and fatigue, but nothing serious. The vaccine made their immune system respond well with antibodies and immune cells. This is good news for the fight against COVID-19.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment